Alligator Bioscience AB (LTS:0RK9) Total Stockholders Equity : kr-76.00 Mil (As of Sep. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Total Stockholders Equity?

Alligator Bioscience AB's Total Stockholders Equity for the quarter that ended in Sep. 2024 was kr-76.00 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Alligator Bioscience AB's Book Value per Share for the quarter that ended in Sep. 2024 was kr-0.10. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Alligator Bioscience AB's Debt-to-Equity for the quarter that ended in Sep. 2024 was -0.13.

Alligator Bioscience AB Total Stockholders Equity Historical Data

The historical data trend for Alligator Bioscience AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Total Stockholders Equity Chart

Alligator Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

258.50

115.24

282.27

89.05

11.86

Alligator Bioscience AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															81.90	11.86	-50.89	-9.51	-76.00

Alligator Bioscience AB (LTS:0RK9) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Alligator Bioscience AB's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(-76.004	-	0)	/	758.039
	=	-0.10

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Alligator Bioscience AB's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(8.61	+	1.351)	/	-76.004
	=	-0.13

Alligator Bioscience AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (LTS:0RK9) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 7AL:Germany

Address

Scheelevagen 2, Medicon Village, Lund, SWE, 223 81

Website

https://www.alligatorbioscience.com

Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB Headlines

No Headlines